Dow Chemical (NYSE:DOW): In an exclusive interview with Andrew Liveris the chairman, president and CEO of Dow Chemical, Cramer talked about his shares for his charitable trust, Action Alerts PLUS, to discuss his firm’s projected merger with DuPont (DD) , especially given that Dow shares has now dropped below $45 a share.
Liveris was rejoicing the inauguration of a novel facility in Freeport, Texas, which transforms propane from shale gas field to propylene, a noteworthy feedstock for numerous products and chemicals. Liveris stated that the Dow facility is the biggest of its kind in the world.
In conjunction with that facility, it is also a new innovation center where more than 900 scientists will work under one roof to establish sustainable solutions.
When questioned on the merger, Liveris cited the $3 billion in collaborations with the combined companies. He stated that Dow is affected by China and other major markets, but the existing negativity will pass, sanctioning the combined companies to embellish.
Lastly, when asked whether the U.S. is currently the world’s most inexpensive producer of natural gas, Liveris replied that the only place to get cheaper gas is in controlled markets, and those markets are quickly converting to free-market pricing like ours.
Novavax (NYSE:NVAX) : In his second exclusive interview, Cramer also talked to Stanley Erck, president and CEO at Novavax, the vaccine manufacturer whose stock plummeted a complete 20% in 2016.
Erck informed that Novavax had a wonderful 2015 and is walking down the same route for 2016. He illustrated that after two positive Phase II trials for their RSV vaccines in 2015, they simply needs to imitate those results in the Phase III trials now ongoing.
The CEO of Novavax also said that they vaccinated 11,850 patients last month and will start amalgamating data from those patients in the third quarter. He added that the corporation is on a predictable path and hopes for no surprises.
Cramer informed that eventually the pessimism in the markets will go away and companies that are doing well, like Novavax, will once again flourish.
Steven Myers
Latest posts by Steven Myers (see all)
- Stanford Researchers Design new Battery that Shuts Down at high temperatures and restarts when it cools down - January 13, 2016
- Dow Chemical and Novavax as the top takeaways - January 13, 2016
- Majority of Young People with Stroke Symptoms Will Avoid ER according to Study - January 12, 2016
